IP Verse

Intermittent Dosing Of Mdm2 Inhibitor

Patent No. EP3160463 (titled "Intermittent Dosing Of Mdm2 Inhibitor") was filed by Novartis on Jun 25, 2015. The application was issued on Oct 21, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BOEHRINGER INGELHEIMJul 16, 2021D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3160463

NOVARTIS
Application Number
EP15733926A
Filing Date
Jun 25, 2015
Status
Opposition Rejected
Nov 10, 2023
Publication Date
Oct 21, 2020
External Links
Slate, Register , Google Patents